switch to tirzepatide from semaglutide Switching Switching from tirzepatide to semaglutide:

How GLP-1s Impact Birth Control Because GLP-1 receptor agonists slow down digestion, they may delay the absorption of oral medications like birth control pills, which could affect ovulation and fertility

Support Saliva Production Saliva is protective

Bruising or Bleeding: Injecting into areas with visible veins or insufficient fat can increase the likelihood of puncturing a blood vessel, leading to bruising or minor bleeding

In subjects with severe RI, the mean exposure of semaglutide was 22% higher than in subjects with normal renal function, and the 95% confidence interval (1.021.47) for the ratio exceeded the pre-specified limits (0.701.43)

By activating GIP receptors alongside GLP-1 receptors, tirzepatide has a more direct influence on lipid handling than a GLP-1-only medication

You have been at your current dose for at least four weeks with no significant GI side effects